Sonali Sethi, MD
Pulmonary Disease · New York, NYNPI 1053519058
Payments from drug & device makers
Across 440 payments — averaging $959.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Noah Medical Corporation$209K
- Ambu A/s$64K
- US Endoscopy$40K
- Erbe Elektromedizin GmbH$35K
- Olympus America Inc.$14K
- Gyrus ACMI, Inc.$12K
- plus $47K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Noah Medical Corporation | 155 | $209,381 |
| Ambu A/s | 11 | $64,139 |
| US Endoscopy | 15 | $40,159 |
| Erbe Elektromedizin GmbH | 1 | $34,529 |
| Olympus America Inc. | 21 | $14,427 |
| Gyrus ACMI, Inc. | 13 | $12,310 |
| Steris Corporation | 41 | $8,792 |
| Intuitive Surgical | 19 | $8,099 |
| Olympus Corporation | 12 | $7,712 |
| Johnson & Johnson | 42 | $5,926 |
| Body Vision Medical Inc. | 21 | $3,806 |
| Boston Scientific | 34 | $2,818 |
| Wilson Cook Medical Incorporated | 2 | $2,481 |
| Pulmonx Corporation | 7 | $1,530 |
| Galvanize Therapeutics, Inc | 13 | $1,241 |
| Getinge USA Sales, LLC | 8 | $1,088 |
| Olympus Medical Systems Corporation | 2 | $990 |
| Covidien LP | 6 | $519 |
| Veran Medical Technologies, Inc. | 1 | $440 |
| Atrium Medical Corporation | 1 | $400 |
| Serpex Medical Inc | 2 | $250 |
| Broncus Medical | 1 | $177 |
| Philips North America LLC | 2 | $171 |
| Edwards Lifesciences | 1 | $163 |
| Auris Health, Inc. | 1 | $121 |
| Medtronic | 2 | $114 |
| Cook Medical LLC | 1 | $93 |
| Siemens Medical Solutions USA, Inc. | 1 | $84 |
| Acclarent, Inc | 1 | $81 |
| Olympus Corporation Of The Americas | 1 | $44 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Ambu Inc. | 1 | $13 |
How this compares
$422,120 in reported general payments places this provider in the 95th percentile of 1,115 pulmonary disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in New York
- Linda RogersNew York$7.1M
- Maria PadillaNew York$3.6M
- Juan WisniveskyNew York$3M
- Bushra MinaNew York$2.5M
- Robert KanerNew York$2.3M
- Doreen Addrizzo-HarrisNew York$1.9M
- Emily DimangoNew York$1.4M
- da ZhangNew York$1.3M
- Claire KeatingNew York$1.2M
- Charles PowellNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.